Yüklüyor......
Cost Analysis of New Antibiotics to Treat Multidrug-Resistant Bacterial Infections: Mind the Gap
INTRODUCTION: Guidelines for treatment of multidrug-resistant (MDR) bacteria rely on newly approved antibiotics, with limited evidence of their effectiveness for treating these infections. Data regarding cost of such an approach are lacking. We aimed to evaluate estimated cost of using newly approve...
Kaydedildi:
| Yayımlandı: | Infect Dis Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955006/ https://ncbi.nlm.nih.gov/pubmed/33594649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-021-00412-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|